Stereotaxis Completes $40 Million Credit Facility Read more about Stereotaxis Completes $40 Million Credit Facility
U.S. Veterans Affairs Awards Stereotaxis a Federal Supply Schedule Contract for Innovative EP Solutions Read more about U.S. Veterans Affairs Awards Stereotaxis a Federal Supply Schedule Contract for Innovative EP Solutions
Stereotaxis Announces Underwriters' Exercise of Over-Allotment Option Read more about Stereotaxis Announces Underwriters' Exercise of Over-Allotment Option
Stereotaxis to Present at the Canaccord Genuity Cardiovascular, Diabetes and Obesity Conference Read more about Stereotaxis to Present at the Canaccord Genuity Cardiovascular, Diabetes and Obesity Conference
Stereotaxis Announces Pricing of $14.6 Million Common Stock Offering Read more about Stereotaxis Announces Pricing of $14.6 Million Common Stock Offering
Stereotaxis Receives Commitment to Increase and Extend Credit Facility Read more about Stereotaxis Receives Commitment to Increase and Extend Credit Facility
Stereotaxis Announces Public Offering of Common Stock Read more about Stereotaxis Announces Public Offering of Common Stock
Stereotaxis Awarded $1.5 Million in Grants under the Qualifying Therapeutic Discovery Project Program Read more about Stereotaxis Awarded $1.5 Million in Grants under the Qualifying Therapeutic Discovery Project Program
Stereotaxis Reports Third Quarter Financial Results Read more about Stereotaxis Reports Third Quarter Financial Results
Stereotaxis Announces Third Quarter 2010 Earnings Release Date and Conference Call Read more about Stereotaxis Announces Third Quarter 2010 Earnings Release Date and Conference Call